1 Brand Drugs Market Overview
1.1 Product Overview and Scope of Brand Drugs
1.2 Brand Drugs Segment by Type
1.2.1 Global Brand Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Biopharmaceutical
1.2.3 Chemistry Medicine
1.3 Brand Drugs Segment by Application
1.3.1 Global Brand Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Brand Drugs Market Size Estimates and Forecasts
1.4.1 Global Brand Drugs Revenue 2017-2028
1.4.2 Global Brand Drugs Sales 2017-2028
1.4.3 Brand Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Brand Drugs Market Competition by Manufacturers
2.1 Global Brand Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Brand Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Brand Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Brand Drugs Manufacturing Sites, Area Served, Product Type
2.5 Brand Drugs Market Competitive Situation and Trends
2.5.1 Brand Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Brand Drugs Players Market Share by Revenue
2.5.3 Global Brand Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Brand Drugs Retrospective Market Scenario by Region
3.1 Global Brand Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Brand Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Brand Drugs Market Facts & Figures by Country
3.3.1 North America Brand Drugs Sales by Country
3.3.2 North America Brand Drugs Revenue by Country
3.3.3 the United States
3.3.4 Canada
3.4 Europe Brand Drugs Market Facts & Figures by Country
3.4.1 Europe Brand Drugs Sales by Country
3.4.2 Europe Brand Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 UK
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Brand Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Brand Drugs Sales by Region
3.5.2 Asia Pacific Brand Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Brand Drugs Market Facts & Figures by Country
3.6.1 Latin America Brand Drugs Sales by Country
3.6.2 Latin America Brand Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Brand Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Brand Drugs Sales by Country
3.7.2 Middle East and Africa Brand Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Brand Drugs Historic Market Analysis by Type
4.1 Global Brand Drugs Sales Market Share by Type (2017-2022)
4.2 Global Brand Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Brand Drugs Price by Type (2017-2022)
5 Global Brand Drugs Historic Market Analysis by Application
5.1 Global Brand Drugs Sales Market Share by Application (2017-2022)
5.2 Global Brand Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Brand Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Brand Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Pfizer Brand Drugs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Brand Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Roche Brand Drugs Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Brand Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Sanofi Brand Drugs Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Brand Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Johnson & Johnson Brand Drugs Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Merck & Co. (MSD)
6.5.1 Merck & Co. (MSD) Corporation Information
6.5.2 Merck & Co. (MSD) Description and Business Overview
6.5.3 Merck & Co. (MSD) Brand Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Merck & Co. (MSD) Brand Drugs Product Portfolio
6.5.5 Merck & Co. (MSD) Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Brand Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Novartis Brand Drugs Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 AbbVie
6.6.1 AbbVie Corporation Information
6.6.2 AbbVie Description and Business Overview
6.6.3 AbbVie Brand Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 AbbVie Brand Drugs Product Portfolio
6.7.5 AbbVie Recent Developments/Updates
6.8 Gilead Sciences
6.8.1 Gilead Sciences Corporation Information
6.8.2 Gilead Sciences Description and Business Overview
6.8.3 Gilead Sciences Brand Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Gilead Sciences Brand Drugs Product Portfolio
6.8.5 Gilead Sciences Recent Developments/Updates
6.9 GlaxoSmithKline (GSK)
6.9.1 GlaxoSmithKline (GSK) Corporation Information
6.9.2 GlaxoSmithKline (GSK) Description and Business Overview
6.9.3 GlaxoSmithKline (GSK) Brand Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 GlaxoSmithKline (GSK) Brand Drugs Product Portfolio
6.9.5 GlaxoSmithKline (GSK) Recent Developments/Updates
6.10 Amgen
6.10.1 Amgen Corporation Information
6.10.2 Amgen Description and Business Overview
6.10.3 Amgen Brand Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Amgen Brand Drugs Product Portfolio
6.10.5 Amgen Recent Developments/Updates
6.11 AstraZeneca
6.11.1 AstraZeneca Corporation Information
6.11.2 AstraZeneca Brand Drugs Description and Business Overview
6.11.3 AstraZeneca Brand Drugs Sales, Revenue and Gross Margin (2017-2022)
6.11.4 AstraZeneca Brand Drugs Product Portfolio
6.11.5 AstraZeneca Recent Developments/Updates
6.12 Bristol-Myers Squibb
6.12.1 Bristol-Myers Squibb Corporation Information
6.12.2 Bristol-Myers Squibb Brand Drugs Description and Business Overview
6.12.3 Bristol-Myers Squibb Brand Drugs Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Bristol-Myers Squibb Brand Drugs Product Portfolio
6.12.5 Bristol-Myers Squibb Recent Developments/Updates
6.13 Eli Lilly
6.13.1 Eli Lilly Corporation Information
6.13.2 Eli Lilly Brand Drugs Description and Business Overview
6.13.3 Eli Lilly Brand Drugs Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Eli Lilly Brand Drugs Product Portfolio
6.13.5 Eli Lilly Recent Developments/Updates
6.14 Teva
6.14.1 Teva Corporation Information
6.14.2 Teva Brand Drugs Description and Business Overview
6.14.3 Teva Brand Drugs Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Teva Brand Drugs Product Portfolio
6.14.5 Teva Recent Developments/Updates
6.15 Bayer
6.15.1 Bayer Corporation Information
6.15.2 Bayer Brand Drugs Description and Business Overview
6.15.3 Bayer Brand Drugs Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Bayer Brand Drugs Product Portfolio
6.15.5 Bayer Recent Developments/Updates
6.16 Novo Nordisk
6.16.1 Novo Nordisk Corporation Information
6.16.2 Novo Nordisk Brand Drugs Description and Business Overview
6.16.3 Novo Nordisk Brand Drugs Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Novo Nordisk Brand Drugs Product Portfolio
6.16.5 Novo Nordisk Recent Developments/Updates
6.17 Allergan
6.17.1 Allergan Corporation Information
6.17.2 Allergan Brand Drugs Description and Business Overview
6.17.3 Allergan Brand Drugs Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Allergan Brand Drugs Product Portfolio
6.17.5 Allergan Recent Developments/Updates
6.18 Takeda
6.18.1 Takeda Corporation Information
6.18.2 Takeda Brand Drugs Description and Business Overview
6.18.3 Takeda Brand Drugs Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Takeda Brand Drugs Product Portfolio
6.18.5 Takeda Recent Developments/Updates
6.19 Boehringer Ingelheim
6.19.1 Boehringer Ingelheim Corporation Information
6.19.2 Boehringer Ingelheim Brand Drugs Description and Business Overview
6.19.3 Boehringer Ingelheim Brand Drugs Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Boehringer Ingelheim Brand Drugs Product Portfolio
6.19.5 Boehringer Ingelheim Recent Developments/Updates
6.20 Takeda
6.20.1 Takeda Corporation Information
6.20.2 Takeda Brand Drugs Description and Business Overview
6.20.3 Takeda Brand Drugs Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Takeda Brand Drugs Product Portfolio
6.20.5 Takeda Recent Developments/Updates
7 Brand Drugs Manufacturing Cost Analysis
7.1 Brand Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Brand Drugs
7.4 Brand Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Brand Drugs Distributors List
8.3 Brand Drugs Customers
9 Brand Drugs Market Dynamics
9.1 Brand Drugs Industry Trends
9.2 Brand Drugs Market Drivers
9.3 Brand Drugs Market Challenges
9.4 Brand Drugs Market Restraints
10 Global Market Forecast
10.1 Brand Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Brand Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Brand Drugs by Type (2023-2028)
10.2 Brand Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Brand Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Brand Drugs by Application (2023-2028)
10.3 Brand Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Brand Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Brand Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
